Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (8) , 1194-1201
- https://doi.org/10.1016/s0959-8049(99)00122-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.Journal of Clinical Oncology, 1998
- Review of recent trials of chemotherapy for advanced breast cancer: the taxanesEuropean Journal Of Cancer, 1997
- Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.Journal of Clinical Oncology, 1994
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancerCancer, 1981
- Reporting results of cancer treatmentCancer, 1981